New Brunswick New Jersey based Ascendia Pharmaceuticals is raising $2,499,945.00 in New Equity Investment.
New Brunswick, NJ – According to filings with the U.S. Securities and Exchange Commission, Ascendia Pharmaceuticals is raising $2,499,945.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Jingjun…